These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3244478)

  • 21. Prevalence of anti-LAV/HTLV-III in Portuguese drug addicts and hemodialyzed patients.
    Lecour H; Santos Ferreira M; Lourenço M; Pestana M; Seara A; Cerqueira Magro F; Fernandes S; Loureiro A; Amaral I; Rodrigues A
    Chemioterapia; 1987 Jun; 6(2 Suppl):635-6. PubMed ID: 3509511
    [No Abstract]   [Full Text] [Related]  

  • 22. [Concentration test for determination of low-level HBsAg in donors with anti-HBc].
    Maschio C; Varrassi S; Barnabei R; Rughetti A; Fonzi D; Capulli M; Genise S
    Riv Emoter Immunoematol; 1985; 32(1):69-73. PubMed ID: 4081534
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunoglobulin M antibody to hepatitis B core antigen (IgM anti-HBc) as a marker of interferon therapy in patients with persistent hepatitis B virus infection.
    Nakajima E; Tsuji T; Kachi K; Kagawa K; Okanoue T; Takino T; Yamada A; Imanishi J
    Biken J; 1987 Mar; 30(1):17-23. PubMed ID: 3675547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of an enzyme assay for detection of hepatitis B virus core IGM antibodies].
    Uzcátegui N; Flores J; Liprandi F; Pujol FH
    Invest Clin; 1998 Mar; 39(1):19-28. PubMed ID: 9586397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of isolated hepatitis B core antibody in blood donors.
    Schifman RB; Rivers SL; Sampliner RE; Krammes JE
    Arch Intern Med; 1993 Oct; 153(19):2261-6. PubMed ID: 8215729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-HBc assays: evaluation of end-point sensitivity and performance.
    Bailey MH; Howel DR; Barbara JA
    Br J Biomed Sci; 1994 Dec; 51(4):341-4. PubMed ID: 7756941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of the hepatitis B core antigen produced in Escherichia coli in an assay for anti-HBc.
    Peutherer JF; MacKay P; Ross R; Stahl S; Murray K
    Med Lab Sci; 1981 Oct; 38(4):355-8. PubMed ID: 7035782
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence of antibodies against human T-lymphotropic virus type III (HTLV-III) in parenteral drug addicts in the Barcelona area].
    Muga R; Tor J; Argelagués E; Rey-Joly C; Foz M; Ribas-Mundó M
    Med Clin (Barc); 1986 Jan; 86(3):97-9. PubMed ID: 3457230
    [No Abstract]   [Full Text] [Related]  

  • 29. [The detection of anti-HBc by a passive hemagglutination method].
    Horiike N; Ogawa Y; Michitaka K; Onji M; Ohta Y
    Rinsho Byori; 1985 Oct; 33(10):1133-7. PubMed ID: 4087439
    [No Abstract]   [Full Text] [Related]  

  • 30. [Significance of "anti HBC alone" serological profile in 284 patients suspicious of being infected with hepatitis B virus].
    Berrajah-Fki L; Ben Halima S; Guermazi F; Hammami A; Karray-Hakim H
    Ann Biol Clin (Paris); 2006; 64(5):451-5. PubMed ID: 17040876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of antibody against hepatitis B core antigen (anti-HBc) in chronic diffuse liver diseases].
    Dávid K; Halmy L
    Orv Hetil; 1983 Apr; 124(15):879-84. PubMed ID: 6856288
    [No Abstract]   [Full Text] [Related]  

  • 32. [Radioimmunoassay for the demonstration of anti-HB-core antibody (HBcAb, anti-HBc (author's transl)].
    Kselíková M; Novák J; Urbánková J
    Radiobiol Radiother (Berl); 1980; 21(2):197-8. PubMed ID: 7465816
    [No Abstract]   [Full Text] [Related]  

  • 33. Evaluation of anti-HBc IgM estimation by radioimmunoassay for anti-HBc on column separated IgM.
    De Cock KM; Ashcavai M; Govindarajan S; Redeker AG
    Ann Clin Lab Sci; 1987; 17(1):27-31. PubMed ID: 3579205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The presence of hepatitis B antigens and antibodies in the blood of drug addicts].
    van Beek-Verbeek G
    Ned Tijdschr Geneeskd; 1979 Jul; 123(27):1144-7. PubMed ID: 460467
    [No Abstract]   [Full Text] [Related]  

  • 35. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
    Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
    Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of specific IgA and IgM anti-HBc antibodies compared with HBV DNA in the sera of HBsAg chronic carriers.
    Elsana S; Shemer-Avni Y; Sikuler E; Sarov B; Naggan L; Bar-Shany S; Gilon E; Yaari A; Orgel M; Frazer GM; Margalith M
    J Hum Virol; 1997; 1(1):52-7. PubMed ID: 10195231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of IgM-class anti-HBc antibodies: which commercial test to choose?].
    Pelletier G; Briantais MJ; Attali P; Pillot J; Etienne JP
    Gastroenterol Clin Biol; 1985 Oct; 9(10):744-5. PubMed ID: 4065497
    [No Abstract]   [Full Text] [Related]  

  • 38. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Occult hepatitis B virus infection in patients with non-Hodgkin lymphoma: the need for early diagnosis in anti-Hbc positive patients.
    Persico E; De Renzo A; La Mura V; Bruno S; Masarone M; Torella R; Persico M
    Gut; 2007 Oct; 56(10):1470-1. PubMed ID: 17872574
    [No Abstract]   [Full Text] [Related]  

  • 40. Occult hepatitis B virus infection in HIV-infected patients with isolated hepatitis B core antibody.
    Azadmanesh K; Mohraz M; Aghakhani A; Edalat R; Jam S; Eslamifar A; Banifazl M; Moradmand-Badie B; Ramezani A
    Intervirology; 2008; 51(4):270-4. PubMed ID: 18841029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.